The Hormonal Receptor Status in Breast Cancer can be Altered by Neoadjuvant Chemotherapy: A Meta-Analysis

Predictors of Tumor Progression During Neoadjuvant Chemotherapy in Breast Cancer

(2010) Abigail S. Caudle et al.   JOURNAL OF CLINICAL ONCOLOGY

Predictors of complete pathological response after neoadjuvant systemic therapy for breast cancer

(2009) Marcus C. Tan et al.   AMERICAN JOURNAL OF SURGERY

Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer

(2009) C. Liedtke et al.   ANNALS OF ONCOLOGY

Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?

(2009) C. Simmons et al.   ANNALS OF ONCOLOGY

Change in the hormone receptor status following administration of neoadjuvant chemotherapy and its impact on the long-term outcome in patients with primary breast cancer

(2009) T Hirata et al.   BRITISH JOURNAL OF CANCER

Should a biopsy be recommended to confirm metastatic disease in women with breast cancer?

(2009) Eitan Amir et al.   LANCET ONCOLOGY

Comparison of estrogen receptor, progesterone receptor and Her-2 status in breast cancer pre- and post-neoadjuvant chemotherapy

(2008) Masako Kasami et al.   BREAST